Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant. Article

Web of Science: 000383373905377

Cited authors

  • Gutierrez, K.; Scheuermann, J.; Goldvarg, I.; Joshi, S.; Tyson, G.; Bzowej, N.; Girgrah, N.; Anders, S.; Loss, G.; Therapondos, G.

Publication date

  • 2016

Published in

International Standard Serial Number (ISSN)

  • 1600-6135

Start page

  • 793

End page

  • 794


  • 16